Literature DB >> 21642879

Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum.

Miranda M Lim1, Jinbin Xu, David M Holtzman, Robert H Mach.   

Abstract

The effects of sleep deprivation on dopaminergic systems remain elusive, in part due to the lack of selective ligands for dopamine receptor subtypes. We examined D1, D2, and D3 receptor density in the mouse brain after sleep deprivation by receptor autoradiography using [H]SCH 23390 for D1R, [H]raclopride for D2R, and [H]WC-10 for D3R (a novel D3R-selective compound developed in our laboratory, not previously reported in mouse). Sleep-deprived mice showed a significant decrease in D1R, no change in D2R, and a significant increase in D3R binding in striatum. This pattern of dopamine receptor changes was not seen in mice subjected to restraint stress, suggesting specificity to sleep. These data provide evidence that brain dopaminergic circuits are remodeled after sleep deprivation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642879      PMCID: PMC3116438          DOI: 10.1097/WNR.0b013e32834846a0

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  24 in total

Review 1.  Structure and function of dopamine receptors.

Authors:  D Vallone; R Picetti; E Borrelli
Journal:  Neurosci Biobehav Rev       Date:  2000-01       Impact factor: 8.989

2.  Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.

Authors:  Wenhua Chu; Zhude Tu; Elizabeth McElveen; Jinbin Xu; Michelle Taylor; Robert R Luedtke; Robert H Mach
Journal:  Bioorg Med Chem       Date:  2005-01-03       Impact factor: 3.641

3.  Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.

Authors:  M Savasta; A Dubois; B Scatton
Journal:  Brain Res       Date:  1986-06-11       Impact factor: 3.252

4.  Up-regulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat.

Authors:  C Deransart; G B Landwehrmeyer; T J Feuerstein; C H Lücking
Journal:  Brain Res Mol Brain Res       Date:  2001-10-19

Review 5.  What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.

Authors:  Benjamin Boutrel; George F Koob
Journal:  Sleep       Date:  2004-09-15       Impact factor: 5.849

6.  Enhanced dopamine uptake in the striatum following repeated restraint stress.

Authors:  Benjamin J Copeland; Norton H Neff; Maria Hadjiconstantinou
Journal:  Synapse       Date:  2005-09-01       Impact factor: 2.562

7.  Parkinson's disease and sleepiness: an integral part of PD.

Authors:  I Arnulf; E Konofal; M Merino-Andreu; J L Houeto; V Mesnage; M L Welter; L Lacomblez; J L Golmard; J P Derenne; Y Agid
Journal:  Neurology       Date:  2002-04-09       Impact factor: 9.910

Review 8.  The physiology, signaling, and pharmacology of dopamine receptors.

Authors:  Jean-Martin Beaulieu; Raul R Gainetdinov
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

9.  Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation.

Authors:  G P Nunes Júnior; S Tufik; J N Nobrega
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

10.  Imaging endogenous dopamine competition with [11C]raclopride in the human brain.

Authors:  N D Volkow; G J Wang; J S Fowler; J Logan; D Schlyer; R Hitzemann; J Lieberman; B Angrist; N Pappas; R MacGregor
Journal:  Synapse       Date:  1994-04       Impact factor: 2.562

View more
  17 in total

Review 1.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

2.  Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain.

Authors:  Nora D Volkow; Dardo Tomasi; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Helene Benveniste; Ron Kim; Panayotis K Thanos; Sergi Ferré
Journal:  J Neurosci       Date:  2012-05-09       Impact factor: 6.167

3.  Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism.

Authors:  Mo Xu; Jerry K Bohlen; Cynthia Moore; Michelle A Nipper; Deborah A Finn; Carolyn E Jones; Miranda M Lim; Charles K Meshul
Journal:  J Neurosci Res       Date:  2019-09-18       Impact factor: 4.164

Review 4.  The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism.

Authors:  Patrick H Finan; Michael T Smith
Journal:  Sleep Med Rev       Date:  2012-06-29       Impact factor: 11.609

5.  Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist.

Authors:  Jinbin Xu; Suwanna Vangveravong; Shihong Li; Jinda Fan; Lynne A Jones; Jinquan Cui; Ruike Wang; Zhude Tu; Wenhua Chu; Joel S Perlmutter; Robert H Mach
Journal:  Neuroimage       Date:  2013-01-17       Impact factor: 6.556

6.  Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease.

Authors:  J Sun; N J Cairns; J S Perlmutter; R H Mach; J Xu
Journal:  Neuroscience       Date:  2013-06-01       Impact factor: 3.590

7.  Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson's disease.

Authors:  E Lauretti; A Di Meco; S Merali; D Praticò
Journal:  Mol Psychiatry       Date:  2016-04-05       Impact factor: 15.992

8.  Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson's disease.

Authors:  E Lauretti; A Di Meco; S Merali; D Praticò
Journal:  Transl Psychiatry       Date:  2016-02-09       Impact factor: 6.222

9.  Stress-Induced Reduction of Dorsal Striatal D2 Dopamine Receptors Prevents Retention of a Newly Acquired Adaptive Coping Strategy.

Authors:  Paolo Campus; Sonia Canterini; Cristina Orsini; Maria Teresa Fiorenza; Stefano Puglisi-Allegra; Simona Cabib
Journal:  Front Pharmacol       Date:  2017-09-12       Impact factor: 5.810

10.  Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.

Authors:  Jianjun Sun; Jinbin Xu; Nigel J Cairns; Joel S Perlmutter; Robert H Mach
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.